The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
An emerging body of literature demonstrates differences in the gut microbiome (GMB) of patients with major depressive disorder (MDD) compared to healthy controls (HC), as well as the potential benefits of prebiotic, probiotic, and synbiotic treatment. We conducted a systematic review of 24 observational studies (n = 2817), and 19 interventional trials (n = 1119). We assessed alpha diversity, beta diversity, and taxa abundance changes in patients with MDD relative to HC, as well as the effect of prebiotics, probiotics, and synbiotics on depressive symptoms in individuals with clinical or subclinical depression. We observed no significant differences in alpha diversity but a significant difference in beta diversity between patients with MDD and HC. There were fluctuations in the abundance of specific taxa in patients with MDD relative to HC. Probiotic and synbiotic, but not prebiotic, treatment showed a modest benefit in reducing depressive symptoms in patients with MDD over four to nine weeks. The GMB profiles of patients with MDD differ significantly from HC, but further studies are needed to elucidate the benefits of prebiotic, probiotic and synbiotic treatments relative to antidepressants and over longer follow-up before these therapies are implemented into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Modified Prisma Flow Diagram [54] for the observational studies on gut microbiome changes in patients with major depressive disorder included in the systematic review.](https://figures.cochat.ai/paper-figures/4cef0daf9a234cb4887a7b7365b260fb/the-gut-microbiome-in-depression-and-potential-benefit-of-prebiotics-probiotics-figure-1.jpg)
![Figure 2 Modified Prisma Flow Diagram [54] for the clinical trials on prebiotics, probiotics and synbiotics in patients with major depressive disorder included in the systematic review.](https://figures.cochat.ai/paper-figures/d29e95b379544cf6899d25bf0ca0890c/the-gut-microbiome-in-depression-and-potential-benefit-of-prebiotics-probiotics-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other meta-analyses have concluded low to moderate effects of probiotics on diminishing clinical and subclinical symptoms of depression, anxiety, and perceived stress [55,67]”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.105906 · Cited by 11,748
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,667 · cited 1×
“Probiotics are preparations of microorganisms that, when administered, improve gut microbial balance [31], while prebiotics are nondigestible compounds (e.”
BackgroundDiversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533 · cited 1×
“This was in line with the assumption that greater species number and diversity contributed to metabolic functional redundancy and resistance to pathogenic colonization [90,91], preventing disease.”
ResultEVOLUTION AND MEASUREMENT OF SPECIES DIVERSITY
Whittaker, R. H. (1972) · TAXON · doi:10.2307/1218190 · Cited by 5,445
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · cited 1×
“For an in-depth review of the gut brain axis, see this 2019 review by Cryan and colleagues [20].”
BackgroundBravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 2×
“In preclinical studies, administration of the probiotic Bifidobacterium infantis to rats has been shown to reverse experimentallyinduced stress and depression [40], while supplementation with Lactobacillus rhamnosus for 28 days results in a decline in depressive symptom ratings [35].”
BackgroundIndigenous bacteria from the gut microbiota regulate host serotonin biosynthesis
Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015) · Cell · doi:10.1016/j.cell.2015.02.047 · Cited by 3,614
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00025 · Cited by 3,043 · cited 1×
“It is mediated by several molecules, including short chain fatty acids [12], secondary bile acids, GABA neurotransmitters [13], and tryptophan metabolites, which are derived from the microbiota [14–16].”
BackgroundMetabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., & Siuzdak, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812874106 · Cited by 2,677
Self-citationNasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Altered fecal microbiota composition in patients with major depressive disorder
Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., Shi, J., et al. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.016 · Cited by 2,275 · cited 1×
“Bifidobacterium species have been found to have anti-inflammatory effects on stress and depression [100], and are expected to be decreased in MDD.”
BackgroundChang, P. V., Hao, L., Offermanns, S., & Medzhitov, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322269111 · Cited by 2,175 · cited 1×
“These genera have anti-inflammatory properties, and are involved in the production of butyrate, a short chain fatty acid involved in the maintenance of the gastrointestinal mucosa and reduction in pro-inflammatory cytokines [102,103].”
BackgroundZheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.44 · Cited by 2,023 · cited 2×
“Zheng 2016 [57] Analysis: 16S rRNA sequencing Platform: Roche 454 sequencing Region: V3-V5 Pipeline: Mothur Database: RDP No significant difference between MDD and HC (observed species, phylogenetic diversity, Shannon, Simpson).”
MethodThe neuroactive potential of the human gut microbiota in quality of life and depression
Valles-Colomer, M., Falony, G., Darzi, Y., Tigchelaar, E. F., Wang, J., Tito, R. Y., Schiweck, C., Kurilshikov, A., Joossens, M., Wijmenga, C., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0337-x · Cited by 1,963
Kelly, J. R., Borre, Y., O' Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.019 · Cited by 1,683 · cited 3×
“Kelly 2016 [22] Analysis: 16S rRNA sequencing Platform: Illumina MiSeq Region: ND Pipeline: QIIME Database: SILVA Significant decrease in MDD compared to HC (Chao, observed species, phylogenetic diversity).”
BackgroundMethodInfluentialPrevalence of Depression in the Community from 30 Countries between 1994 and 2014
Lim, G. Y., Tam, W. W., Lu, Y., Ho, C. S., Zhang, M. W., & Ho, R. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-21243-x · Cited by 1,557 · cited 1×
“8% in community samples globally [2], it is the most common psychiatric illness worldwide, and a leading cause of disability [3].”
BackgroundSymbiotic bacteria direct expression of an intestinal bactericidal lectin
Cash, H. L., Whitham, C. V., Behrendt, C. L., & Hooper, L. V. (2006) · Science · doi:10.1126/science.1127119 · Cited by 1,432
γ-Aminobutyric acid production by culturable bacteria from the human intestine
Barrett, E., Ross, R. P., O'Toole, P. W., Fitzgerald, G. F., & Stanton, C. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05344.x · Cited by 1,156 · cited 1×
“It is mediated by several molecules, including short chain fatty acids [12], secondary bile acids, GABA neurotransmitters [13], and tryptophan metabolites, which are derived from the microbiota [14–16].”
BackgroundEffects of the probiotic Bifidobacterium infantis in the maternal separation model of depression
Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J. F., & Dinan, T. G. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.005 · Cited by 999 · cited 1×
“In preclinical studies, administration of the probiotic Bifidobacterium infantis to rats has been shown to reverse experimentallyinduced stress and depression [40], while supplementation with Lactobacillus rhamnosus for 28 days results in a decline in depressive symptom ratings [35].”
BackgroundProbiotics in the management of atopic eczema
Isolauri, E., Arvola, T., SÜtas, Y., Moilanen, E., & Salminen, S. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00943.x · Cited by 974
Angiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929
The gut microbiota in anxiety and depression—A systematic review
Simpson, C. A., Diaz-Arteche, C., Eliby, D., Schwartz, O. S., Simmons, J. G., & Cowan, C. S. M. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101943 · Cited by 912 · cited 3×
“An association of Eggerthella with increased gastrointestinal inflammation has also been noted in patients with MDD, and further supports the idea that depression involves inflammatory states [95,99].”
BackgroundResultThe gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology
Rutsch, A., Kantsjö, J. B., & Ronchi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604179 · Cited by 821 · cited 1×
“During dysbiosis, or a disruption to microbiota homeostasis, gut–brain pathways are dysregulated and associated with neuroinflammation and altered permeability of the blood–brain barrier [17].”
BackgroundAkkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016) · Nutrition · doi:10.1016/j.nut.2015.09.003 · Cited by 767 · cited 6×
“Abbreviations: CES-D, Center for Epidemiological Studies Depression Scale; Ctr, control; DASS-42-D, depression subscale of the Depression, Anxiety and Stress Scale; DB, double-blind; DSM-IV-TR, Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revision; DSM-IV, Diagnostic and Statistical Manual…”
BackgroundInfluentialPerturbations in Gut Microbiota Composition in Psychiatric Disorders: A Review and Meta-analysis
Nikolova, V. L., Smith, M. R. B., Hall, L. J., Cleare, A. J., Stone, J. M., & Young, A. H. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.2573 · Cited by 731 · cited 4×
“Nikolova and colleagues (2021), observed a decrease in Coprococcus and Faecalibacterium across several psychiatric disorders [92].”
BackgroundResultInfluential(2000) · PubMed · Cited by 685
Sex differences in gut microbiota
Kim, Y. S., Unno, T., Kim, B.-Y., & Park, M.-S. (2020) · The World Journal of Men s Health · doi:10.5534/wjmh.190009 · Cited by 610
Pathophysiology of depression: do we have any solid evidence of interest to clinicians?
HASLER, G. (2010) · World Psychiatry · doi:10.1002/j.2051-5545.2010.tb00298.x · Cited by 604
Review article: dietary fibre-microbiota interactions
Simpson, H. L., & Campbell, B. J. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13248 · Cited by 602
Systematic Review of Gut Microbiota and Major Depression
Cheung, S. G., Goldenthal, A. R., Uhlemann, A.-C., Mann, J. J., Miller, J. M., & Sublette, M. E. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00034 · Cited by 597 · cited 4×
“These results are consistent with the findings from three other reviews [43,47,92].”
BackgroundResultInfluentialAizawa, E., Tsuji, H., Asahara, T., Takahashi, T., Teraishi, T., Yoshida, S., Ota, M., Koga, N., Hattori, K., & Kunugi, H. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.038 · Cited by 576 · cited 2×
“Aizawa 2016 [55] Cross-Sectional Japan MDD (N = 43) HC (N = 57) DSM-IV MDD: 41.”
MethodLiu, R. T., Walsh, R. F. L., & Sheehan, A. E. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.023 · Cited by 564
Kazemi, A., Noorbala, A. A., Azam, K., Eskandari, M. H., & Djafarian, K. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.04.010 · Cited by 534 · cited 4×
“An additional two studies [75,79] compared the benefits of the prebiotic galactooligosaccharide relative to the probiotic CEREBIOME® and placebo.”
BackgroundMethodResultInfluentialProbiotics—compensation for lactase insufficiency
de Vrese, M., Stegelmann, A., Richter, B., Fenselau, S., Laue, C., & Schrezenmeir, J. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.421s · Cited by 521
Huang, R., Wang, K., & Hu, J. (2016) · Nutrients · doi:10.3390/nu8080483 · Cited by 505
McGuinness, A. J., Davis, J. A., Dawson, S. L., Loughman, A., Collier, F., O’Hely, M., Simpson, C. A., Green, J., Marx, W., Hair, C., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01456-3 · Cited by 502 · cited 3×
“Our findings are consistent with those of a recent systematic review of gut microbiome composition in patients with MDD, BD, and SZ compared to HC conducted by McGuinness and colleagues (2022) [89].”
BackgroundResultInfluentialRudzki, L., Ostrowska, L., Pawlak, D., Małus, A., Pawlak, K., Waszkiewicz, N., & Szulc, A. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.10.010 · Cited by 499 · cited 1×
“Rudzki 2019 [76] DB RCT Poland MDD (N = 60) DSM-IV-TR Pro: 39.”
Chapter 12: Human Microbiome Analysis
Morgan, X. C., & Huttenhower, C. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002808 · Cited by 496 · cited 3×
“As alpha diversity is a measure of species richness and evenness within a single population [88], these findings suggest that the diversity of the GMB is similar for patients with MDD and HC.”
BackgroundResultInfluentialThe effects of probiotics on depressive symptoms in humans: a systematic review
Wallace, C. J. K., & Milev, R. (2017) · Annals of General Psychiatry · doi:10.1186/s12991-017-0138-2 · Cited by 471
Sorbara, M. T., & Pamer, E. G. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00667-9 · Cited by 468
Diversity is the question, not the answer
Shade, A. (2017) · The ISME Journal · doi:10.1038/ismej.2016.118 · Cited by 466
Gut Microbiota and Inflammation
Hakansson, A., & Molin, G. (2011) · Nutrients · doi:10.3390/nu3060637 · Cited by 455
Altered Composition of Gut Microbiota in Depression: A Systematic Review
Barandouzi, Z. A., Starkweather, A. R., Henderson, W. A., Gyamfi, A., & Cong, X. S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00541 · Cited by 454 · cited 5×
“Decreased levels of Bacteroidetes have also been observed in females compared to males, and females were overrepresented among patients with MDD relative to HC in the observational studies [104].”
ResultInfluentialForbes, J. D., Chen, C.-Y., Knox, N. C., Marrie, R.-A., El-Gabalawy, H., de Kievit, T., Alfa, M., Bernstein, C. N., & Van Domselaar, G. (2018) · Microbiome · doi:10.1186/s40168-018-0603-4 · Cited by 450 · cited 1×
“An association of Eggerthella with increased gastrointestinal inflammation has also been noted in patients with MDD, and further supports the idea that depression involves inflammatory states [95,99].”
BackgroundAit‐Belgnaoui, A., Colom, A., Braniste, V., Ramalho, L., Marrot, A., Cartier, C., Houdeau, E., Theodorou, V., & Tompkins, T. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12295 · Cited by 434 · cited 2×
“Mucosal integrity is important for preventing endotoxins from entering the circulation and reducing uncontrolled inflammation [36].”
BackgroundMetagenome-wide association of gut microbiome features for schizophrenia
Zhu, F., Ju, Y., Wang, W., Wang, Q., Guo, R., Ma, Q., Sun, Q., Fan, Y., Xie, Y., Yang, Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15457-9 · Cited by 409
Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders
Yang, J., Zheng, P., Li, Y., Wu, J., Tan, X., Zhou, J., Sun, Z., Chen, X., Zhang, G., Zhang, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba8555 · Cited by 407 · cited 8×
“Yang 2020 [26] Sequencing: SMS Platform: Illumina NovaSeq Database: KEGG, NCBI NR No significant difference between MDD and HC (Chao, Shannon, Simpson, Inverse Simpson).”
BackgroundMethodInfluentialSchauber, J. (2003) · Gut · doi:10.1136/gut.52.5.735 · Cited by 383
Gut microbiota and major depressive disorder: a systematic review and meta-analysis
Sanada, K., Nakajima, S., Kurokawa, S., Barceló-Soler, A., Ikuse, D., Hirata, A., Yoshizawa, A., Tomizawa, Y., Salas-Valero, M., Noda, Y., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.102 · Cited by 372 · cited 2×
“These results are consistent with the findings from three other reviews [43,47,92].”
BackgroundResultGuida, F., Turco, F., Iannotta, M., De Gregorio, D., Palumbo, I., Sarnelli, G., Furiano, A., Napolitano, F., Boccella, S., Luongo, L., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.09.001 · Cited by 367 · cited 1×
“A study by Guida and colleagues (2017) revealed that antibiotic-induced dysbiosis in mice led to a general inflammatory state, and depressive-type behaviour, but was reversed with the probiotic Lactobacillus casei [21].”
BackgroundTian, P., Chen, Y., Zhu, H., Wang, L., Qian, X., Zou, R., Zhao, J., Zhang, H., Qian, L., Wang, Q., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.11.023 · Cited by 356 · cited 9×
“Sci. 2022, 23, 4494 12 of 27 Streptococcus Faecalibacterium a Taxa abundance changes observed in four or more studies are presented here.”
BackgroundInfluentialRomijn, A. R., Rucklidge, J. J., Kuijer, R. G., & Frampton, C. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416686694 · Cited by 323 · cited 1×
“Romijn 2017 [72] DB RCT New Zealand Low mood (N = 79) QIDS-SR16 ≥ 11; DASS-42-D ≥ 14 Pro: 35.”
Lin, P., Ding, B., Feng, C., Yin, S., Zhang, T., Qi, X., Lv, H., Guo, X., Dong, K., Zhu, Y., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.051 · Cited by 311 · cited 2×
“Lin 2017 [58] Prospective China MDD (N = 10) HC (N = 10) DSM-IV HAM-D ≥ 23 MDD: 36.”
MethodPossible association of Firmicutes in the gut microbiota of patients with major depressive disorder
Huang, Y., Shi, X., Li, Z., Shen, Y., Shi, X., Wang, L., Li, G., Yuan, Y., Wang, J., Zhang, Y., et al. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s188340 · Cited by 307 · cited 2×
“Huang 2018 [59] Analysis: 16S rRNA sequencing Platform: Illumina HiSeq Region: V3-V4 Pipeline: QIIME Database: GreenGenes Significant decrease in MDD compared to HC (ACE, Chao, phylogenetic diversity, Shannon).”
MethodLiu, Y., Zhang, L., Wang, X., Wang, Z., Zhang, J., Jiang, R., Wang, X., Wang, K., Liu, Z., Xia, Z., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.05.033 · Cited by 301 · cited 5×
“Abbreviations: a-MDD, active-major depressive disorder; r-MDD, Major depressive disorder in remission or with only mild symptoms; BD-D, Bipolar disorder in current depressive episode; BD, Bipolar disorder; COMO, comorbid irritable bowel syndrome and depression; D-HC; Discovery set of healthy controls; D-MDD, Discovery…”
MethodInfluentialGut microbiota diversity according to dietary habits and geographical provenance
Senghor, B., Sokhna, C., Ruimy, R., & Lagier, J.-C. (2018) · Human Microbiome Journal · doi:10.1016/j.humic.2018.01.001 · Cited by 299
Lukić, I., Getselter, D., Ziv, O., Oron, O., Reuveni, E., Koren, O., & Elliott, E. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0466-x · Cited by 273
Sex differences in gut microbiota in patients with major depressive disorder
Chen, J.-J., Zheng, P., Liu, Y.-Y., Zhong, X.-G., Wang, H.-Y., Guo, Y.-J., & Xie, P. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s159322 · Cited by 272 · cited 2×
“Chen 2018a [62] Analysis: 16S rRNA sequencing Platform: Roche 454 sequencing Region: V3-V5 Pipeline: Mothur Database: RDP No significant difference between MDD and HC (phylogenetic diversity).”
MethodMacedo, D., Filho, A. J. M. C., Soares de Sousa, C. N., Quevedo, J., Barichello, T., Júnior, H. V. N., & Freitas de Lucena, D. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.012 · Cited by 261
Chahwan, B., Kwan, S., Isik, A., van Hemert, S., Burke, C., & Roberts, L. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.097 · Cited by 256 · cited 3×
“Chahwan 2019 [77] TB RCT Australia Clinical and sub-clinical depression (N = 71) MINI-IV Pro: 36.”
BackgroundBerlim, M. T., & Turecki, G. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.009 · Cited by 249 · cited 1×
“However, there are several limitations to this model, including the fact that up to 30% of patients with MDD do not respond to monoaminergic antidepressants [5], these medications are effective in psychiatric disorders with differing”
BackgroundLiu, R. T., Rowan-Nash, A. D., Sheehan, A. E., Walsh, R. F. L., Sanzari, C. M., Korry, B. J., & Belenky, P. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.03.026 · Cited by 242 · cited 2×
“Liu 2020 [24] Cross-Sectional USA MDD (N = 43) HC (N = 47) SCID-4 MDD: 21.”
MethodA review on measurement of Alpha diversity in biology
Thukral, A. K. (2017) · Agricultural Research Journal · doi:10.5958/2395-146x.2017.00001.1 · Cited by 220
Current perspectives on gut microbiome dysbiosis and depression
Capuco, A., Urits, I., Hasoon, J., Chun, R., Gerald, B., Wang, J. K., Kassem, H., Ngo, A. L., Abd-Elsayed, A., Simopoulos, T., et al. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01272-7 · Cited by 216 · cited 1×
“Our observations are consistent with findings in patients with MDD [47], and psychiatric disorders more generally where changes in beta diversity have been noted [92], and aligns with the hypothesis that MDD involves a dysbiotic state [96].”
ResultOn the Use of Diversity Measures in Longitudinal Sequencing Studies of Microbial Communities
Wagner, B. D., Grunwald, G. K., Zerbe, G. O., Mikulich-Gilbertson, S. K., Robertson, C. E., Zemanick, E. T., & Harris, J. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01037 · Cited by 195
Exploration of microbiota targets for major depressive disorder and mood related traits
Chung, Y.-C. E., Chen, H.-C., Chou, H.-C. L., Chen, I.-M., Lee, M.-S., Chuang, L.-C., Liu, Y.-W., Lu, M.-L., Chen, C.-H., Wu, C.-S., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.01.016 · Cited by 194 · cited 2×
“Chung 2019 [23] Cross-Sectional Taiwan MDD (N = 36) HC (N = 37) DSM-IV MDD: 45.”
MethodCrosstalk between the microbiota-gut-brain axis and depression
Du, Y., Gao, X.-R., Peng, L., & Ge, J.-F. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04097 · Cited by 191
Miyaoka, T., Kanayama, M., Wake, R., Hashioka, S., Hayashida, M., Nagahama, M., Okazaki, S., Yamashita, S., Miura, S., Miki, H., et al. (2018) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000299 · Cited by 186 · cited 1×
“Miyaoka 2018 [74] Prospective open-label trial Japan TRD (N = 40) DSM-IV-TR Pro: 44.”
Rong, H., Xie, X.-H., Zhao, J., Lai, W.-T., Wang, M.-B., Xu, D., Liu, Y.-H., Guo, Y.-Y., Xu, S.-X., Deng, W.-F., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.03.017 · Cited by 185 · cited 9×
“While human interventional trials are only beginning to gain traction, preliminary evidence from observational studies has shown that the gut microbiome (GMB) profiles of patients with MDD and depressive symptoms differ significantly from healthy controls (HC) [23–27], as well as patients with other mood [28,29] and a…”
BackgroundMethodInfluentialChen, Z., Li, J., Gui, S., Zhou, C., Chen, J., Yang, C., Hu, Z., Wang, H., Zhong, X., Zeng, L., et al. (2018) · NeuroReport · doi:10.1097/wnr.0000000000000985 · Cited by 181 · cited 3×
“Chen 2018b [61] Cross-Sectional China MDD (N = 10) HC (N = 10) DSM-IV HAM-D ≥ 20 MDD: 43.”
BackgroundGut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression
Zheng, P., Yang, J., Li, Y., Wu, J., Liang, W., Yin, B., Tan, X., Huang, Y., Chai, T., Zhang, H., et al. (2020) · Advanced Science · doi:10.1002/advs.201902862 · Cited by 175 · cited 3×
“We also included six studies that involved patients with IBS [56], BD [28,29,69], and anxiety [30,65] as they had subsamples of patients with MDD and HC alone.”
MethodShishov, V. A., Kirovskaya, T. A., Kudrin, V. S., & Oleskin, A. V. (2009) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683809050068 · Cited by 174
Ansari, F., Pourjafar, H., Tabrizi, A., & Homayouni, A. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666200107113812 · Cited by 170
Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii
Miquel, S., Martín, R., Bridonneau, C., Robert, V., Sokol, H., Bermúdez-Humarán, L. G., Thomas, M., & Langella, P. (2014) · Gut Microbes · doi:10.4161/gmic.27651 · Cited by 170 · cited 1×
“These genera have anti-inflammatory properties, and are involved in the production of butyrate, a short chain fatty acid involved in the maintenance of the gastrointestinal mucosa and reduction in pro-inflammatory cytokines [102,103].”
BackgroundPrebiotics: Definition and protective mechanisms
Valcheva, R., & Dieleman, L. A. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.008 · Cited by 162 · cited 1×
“, fructooligosaccharides, galacto-oligosaccharides, and xylooligosaccharides) that are metabolized by gut microorganisms, modulating GMB composition to ultimately benefit the host [32].”
BackgroundPROVIT: Supplementary Probiotic Treatment and Vitamin B7 in Depression—A Randomized Controlled Trial
Reininghaus, E. Z., Platzer, M., Kohlhammer-Dohr, A., Hamm, C., Mörkl, S., Bengesser, S. A., Fellendorf, F. T., Lahousen-Luxenberger, T., Leitner-Afschar, B., Schöggl, H., et al. (2020) · Nutrients · doi:10.3390/nu12113422 · Cited by 157 · cited 8×
“Nikolova and colleagues (2021), observed a decrease in Coprococcus and Faecalibacterium across several psychiatric disorders [92].”
BackgroundMethodInfluentialRole of inflammatory cytokines in depression: Focus on interleukin-1β
Farooq, R. K., Asghar, K., Kanwal, S., & Zulqernain, A. (2017) · Biomedical Reports · doi:10.3892/br.2016.807 · Cited by 153 · cited 1×
“For example, depression is associated with the release of C-reactive protein (CRP) and cytokines such as IL-1, IL-2, IL-6, IFN-γ, and IL-1β [19].”
BackgroundGut microbiota changes in children with autism spectrum disorder: a systematic review
Ho, L. K. H., Tong, V. J. W., Syn, N., Nagarajan, N., Tham, E. H., Tay, S. K., Shorey, S., Tambyah, P. A., & Law, E. C. N. (2020) · Gut Pathogens · doi:10.1186/s13099-020-0346-1 · Cited by 149 · cited 1×
“Equivocal alpha diversity findings have also been reported in neuropsychiatric diseases with similar pathophysiologies to depression, including Parkinson’s disease [93], autism spectrum disorder [94], and anxiety [95].”
BackgroundLai, W.-T., Deng, W.-F., Xu, S.-X., Zhao, J., Xu, D., Liu, Y.-H., Guo, Y.-Y., Wang, M.-B., He, F.-S., Ye, S.-W., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291719003027 · Cited by 146 · cited 8×
“Lai 2021 [68] Cross-Sectional China MDD (N = 26) HC (N = 29) SCID-V HAM-D > 17 MDD: 43.”
BackgroundMethodInfluentialZhang, X., Chen, S., Zhang, M., Ren, F., Ren, Y., Li, Y., Liu, N., Zhang, Y., Zhang, Q., & Wang, R. (2021) · Nutrients · doi:10.3390/nu13072238 · Cited by 136 · cited 3×
“Zhang 2021 [86] DB RCT China MDD (N = 69) DSM-V Pro: 45.”
BackgroundThe mechanistic link between health and gut microbiota diversity
Larsen, O. F. A., & Claassen, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-20141-6 · Cited by 133 · cited 1×
“This was in line with the assumption that greater species number and diversity contributed to metabolic functional redundancy and resistance to pathogenic colonization [90,91], preventing disease.”
ResultLi, N., Wang, Q., Wang, Y., Sun, A., Lin, Y., Jin, Y., & Li, X. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00266 · Cited by 128 · cited 1×
“Probiotic supplementation attenuated anxiety and depressive-like behaviors, significantly increased Lactobacillus abundance, and reversed immune changes [41].”
BackgroundGhorbani, Z., Nazari, S., Etesam, F., Nourimajd, S., Ahmadpanah, M., & Razeghi Jahromi, S. (2018) · Archives of Neuroscience · doi:10.5812/archneurosci.60507 · Cited by 127 · cited 4×
“Ghorbani 2018 [73] MDD (N = 40) Familact H®a Syn, Fluoxetine Plb, Fluoxetine 8 weeks HAMD-17 Significant decrease in HAMD-17 score in synbiotic group compared to placebo over 8 weeks.”
BackgroundMethodInfluentialReduced anti-inflammatory gut microbiota are associated with depression and anhedonia
Mason, B. L., Li, Q., Minhajuddin, A., Czysz, A. H., Coughlin, L. A., Hussain, S. K., Koh, A. Y., & Trivedi, M. H. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.137 · Cited by 126 · cited 4×
“We also included six studies that involved patients with IBS [56], BD [28,29,69], and anxiety [30,65] as they had subsamples of patients with MDD and HC alone.”
BackgroundMethodInfluentialEffect of probiotics on depressive symptoms: a meta-analysis of human studies
Goh, K. K., Liu, Y.-W., Kuo, P.-H., Chung, Y.-C. E., Lu, M.-L., & Chen, C.-H. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112568 · Cited by 123
Wallace, C. J. K., & Milev, R. V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.618279 · Cited by 119 · cited 6×
“Wallace 2021 [53] Open pilot study Canada MDD (N = 10) MINI-IV; MADRS ≥ 20 Pro: 25.”
BackgroundResultInfluentialCaso, J. R., MacDowell, K. S., González-Pinto, A., García, S., de Diego-Adeliño, J., Carceller-Sindreu, M., Sarramea, F., Caballero-Villarraso, J., Gracia-García, P., De la Cámara, C., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01755-3 · Cited by 107 · cited 3×
“Caso 2021 [67] Analysis: 16S rDNA sequencing Platform: Illumina MiSeq Region: V3-V4 Pipeline: QIIME, Calypso Database: RDP No significant difference between MDD and HC (Shannon).”
BackgroundMethodNuzum, N. D., Loughman, A., Szymlek-Gay, E. A., Hendy, A., Teo, W.-P., & Macpherson, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.003 · Cited by 103 · cited 1×
“Equivocal alpha diversity findings have also been reported in neuropsychiatric diseases with similar pathophysiologies to depression, including Parkinson’s disease [93], autism spectrum disorder [94], and anxiety [95].”
BackgroundIn Silico Analysis of Putrefaction Pathways in Bacteria and Its Implication in Colorectal Cancer
Kaur, H., Das, C., & Mande, S. S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02166 · Cited by 98
Sanctuary, M. R., Kain, J. N., Angkustsiri, K., & German, J. B. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00040 · Cited by 96
Probiotics and prebiotics: focus on psychiatric disorders – a systematic review
Barbosa, R. S. D., & Vieira-Coelho, M. A. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuz080 · Cited by 93
Gut Microbiome Composition Associated With Major Depressive Disorder and Sleep Quality
Zhang, Q., Yun, Y., An, H., Zhao, W., Ma, T., Wang, Z., & Yang, F. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.645045 · Cited by 88
Bambling, M., Edwards, S. C., Hall, S., & Vitetta, L. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0311-x · Cited by 87 · cited 6×
“Abbreviations: CES-D, Center for Epidemiological Studies Depression Scale; Ctr, control; DASS-42-D, depression subscale of the Depression, Anxiety and Stress Scale; DB, double-blind; DSM-IV-TR, Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revision; DSM-IV, Diagnostic and Statistical Manual…”
BackgroundResultInfluentialMinayo, M. D. S., Miranda, I., & Telhado, R. S. (2021) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232021269.21342020 · Cited by 87
Heidarzadeh-Rad, N., Gökmen-Özel, H., Kazemi, A., Almasi, N., & Djafarian, K. (2020) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20079 · Cited by 86 · cited 4×
“An additional two studies [75,79] compared the benefits of the prebiotic galactooligosaccharide relative to the probiotic CEREBIOME® and placebo.”
BackgroundMethodResultInfluentialChen, H., Kuo, P., Hsu, C., Chiu, Y.-H., Liu, Y.-W., Lu, M., & Chen, C.-H. (2021) · Nutrients · doi:10.3390/nu13113731 · Cited by 86 · cited 1×
“Chen 2021 [84] Open trial Taiwan MDD (N = 11) DSM-V Pro: 39.”
Chen, Y.-H., Xue, F., Yu, S.-F., Li, X.-S., Liu, L., Jia, Y.-Y., Yan, W.-J., Tan, Q.-R., Wang, H.-N., & Peng, Z.-W. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.143 · Cited by 79 · cited 3×
“Chen 2021 [27] Analysis: 16S rRNA sequencing Platform: Illumina MiSeq Region: V3-V4 Pipeline: Mothur, QIIME Database: RDP No significant difference between MDD and HC (ACE, Chao, Shannon, Simpson,).”
BackgroundMethodReiter, A., Bengesser, S. A., Hauschild, A.-C., Birkl-Töglhofer, A.-M., Fellendorf, F. T., Platzer, M., Färber, T., Seidl, M., Mendel, L.-M., Unterweger, R., et al. (2020) · Nutrients · doi:10.3390/nu12092575 · Cited by 78 · cited 2×
“Reiter 2020 [81] DB RCT Austria MDD (N = 61) MINI-IV Pro: 43.”
MethodChen, J.-J., He, S., Fang, L., Wang, B., Bai, S.-J., Xie, J., Zhou, C.-J., Wang, W., & Xie, P. (2020) · Aging · doi:10.18632/aging.102775 · Cited by 76 · cited 2×
“Chen 2020 [25] Analysis: 16S rRNA sequencing Platform: Roche 454 sequencing Region: V3-V5 Pipeline: Mothur Database: RDP No significant difference between MDD and HC (ACE, Chao).”
MethodEl Dib, R., Periyasamy, A. G., de Barros, J. L., França, C. G., Senefonte, F. L., Vesentini, G., Alves, M. G. O., Rodrigues, J. V. D. S., Gomaa, H., Gomes Júnior, J. R., et al. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.07.027 · Cited by 75 · cited 1×
“These findings are supported by those of an earlier systematic review and meta-analysis of 16 RCTs by El Dib and colleagues (2021), which demonstrated significant improvement in depression and anxiety symptoms in patients treated with probiotics according to the BDI and State-Trait Anxiety Inventory (STAI) [50].”
ResultGawlik, S., Waldeier, L. M., Müller, M., Szabo, A., Sohn, C., & Reck, C. (2012) · Archives of Women s Mental Health · doi:10.1007/s00737-012-0320-0 · Cited by 73
Browne, P. D., Bolte, A. C., der Vaart, I. B.-V., Claassen, E., & de Weerth, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-81204-9 · Cited by 71 · cited 4×
“Abbreviations: CES-D, Center for Epidemiological Studies Depression Scale; Ctr, control; DASS-42-D, depression subscale of the Depression, Anxiety and Stress Scale; DB, double-blind; DSM-IV-TR, Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revision; DSM-IV, Diagnostic and Statistical Manual…”
BackgroundMethodInfluentialDong, Z., Shen, X., Hao, Y., Li, J., Li, H., Xu, H., Yin, L., & Kuang, W. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.651536 · Cited by 66
Major Depressive Disorder and gut microbiota – Association not causation. A scoping review
Łoniewski, I., Misera, A., Skonieczna-Żydecka, K., Kaczmarczyk, M., Kaźmierczak-Siedlecka, K., Misiak, B., Marlicz, W., & Samochowiec, J. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110111 · Cited by 61
Awareness, Knowledge, and Interest about Prebiotics—A Study among Romanian Consumers
Precup, G., Pocol, C. B., Teleky, B.-E., & Vodnar, D. C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031208 · Cited by 61 · cited 1×
“The scientific literature classifies prebiotics as functional foods, given their role in promoting health and preventing disease [33].”
BackgroundVaghef‐Mehrabany, E., Ranjbar, F., Jafarabadi, M. A., Hosseinpour-Arjmand, S., & Ebrahimi‐Mameghani, M. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1630985 · Cited by 60 · cited 4×
“One prebiotic study explored the benefits of Inulin 10 g per day [78] relative to placebo.”
BackgroundMethodInfluentialZheng, S., Zhu, Y., Wu, W., Zhang, Q., Wang, Y., Wang, Z., & Yang, F. (2021) · Brain and Behavior · doi:10.1002/brb3.2036 · Cited by 57 · cited 2×
“Zheng 2021 [63] Analysis: 16S rRNA sequencing Platform: Illumina MiSeq Region: ND Pipeline: Mothur Database: ND No significant difference between MDD and HC (ACE, Chao, Shannon, Simpson).”
MethodSchneider, G., Kruse, A., Nehen, H.-G., Senf, W., & Heuft, G. (2000) · Psychotherapy and Psychosomatics · doi:10.1159/000012404 · Cited by 55 · cited 1×
“However, these studies tend to be restricted to patients who meet strict criteria for MDD, at the expense of including more common, subclinical forms of depression that are prevalent in inpatient and healthy populations [51,52] and may be more likely to respond to prebiotic, probiotic, and synbiotic supplementation [5…”
BackgroundMonoamine depletion in unmedicated depressed subjects.
Berman, R., Sanacora, G., Anand, A., Roach, L. M., Fasula, M. K., Finkelstein, C., Wachen, R., Oren, D., Heninger, G., & Charney, D. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01285-9 · Cited by 53 · cited 1×
“pathophysiologies [6], and disruptions of monoamine systems do not exacerbate existing depressive symptoms [7].”
BackgroundHofmeister, M., Clement, F., Patten, S., Li, J., Dowsett, L. E., Farkas, B., Mastikhina, L., Egunsola, O., Diaz, R., Cooke, N. C. A., et al. (2021) · CMAJ Open · doi:10.9778/cmajo.20200283 · Cited by 53 · cited 8×
“Abbreviations: CES-D, Center for Epidemiological Studies Depression Scale; Ctr, control; DASS-42-D, depression subscale of the Depression, Anxiety and Stress Scale; DB, double-blind; DSM-IV-TR, Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revision; DSM-IV, Diagnostic and Statistical Manual…”
BackgroundMethodInfluentialGut microbiome in adolescent depression
Thapa, S., Sheu, J. C., Venkatachalam, A., Runge, J. K., Luna, R. A., & Calarge, C. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.05.107 · Cited by 51 · cited 2×
“Thapa 2021 [60] Longitudinal USA MDD (N = 110) HC (N = 27) Psy ctr (N = 23) DSM-IV-TR MDD: 19.”
MethodBai, S., Xie, J., Bai, H., Tian, T., Zou, T., & Chen, J.-J. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s324922 · Cited by 51 · cited 2×
“Bai 2021 [66] Analysis: 16S rRNA sequencing Platform: ND Region: ND Pipeline: ND Database: RDP No significant difference between MDD and HC (Chao, Shannon, Simpson, phylogenetic diversity).”
MethodChen, C., & Shan, W. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112595 · Cited by 49
Comparison of serum microbiome composition in bipolar and major depressive disorders
Rhee, S. J., Kim, H.-Y., Lee, Y., Lee, H. J., Park, C. H. K., Yang, J., Kim, Y.-K., Kym, S., & Ahn, Y. M. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.01.004 · Cited by 43 · cited 5×
“While human interventional trials are only beginning to gain traction, preliminary evidence from observational studies has shown that the gut microbiome (GMB) profiles of patients with MDD and depressive symptoms differ significantly from healthy controls (HC) [23–27], as well as patients with other mood [28,29] and a…”
BackgroundMethodInfluentialSaccarello, A., Montarsolo, P., Massardo, I., Picciotto, R., Pedemonte, A., Castagnaro, R., Brasesco, P. C., Guida, V., Picco, P., Fioravanti, P., et al. (2020) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.19m02578 · Cited by 37 · cited 2×
“Saccarello 2020 [82] MDD (N = 90) SAMe, L.”
Erratum to: The effects of probiotics on depressive symptoms in humans: a systematic review
Wallace, C. J. K., & Milev, R. V. (2017) · Annals of General Psychiatry · doi:10.1186/s12991-017-0141-7 · Cited by 24
The role of probiotics in combination therapy of depressive disorders
Arifdjanova, S. R., Abrurakhmanova, Z. Z., Bizulya, E. S., Николаевна, Г. Л., Sorokina, L. E., & Gerbali, O. Y. (2021) · Russian Open Medical Journal · doi:10.15275/rusomj.2021.0109 · Cited by 22
Lactobacillus GG Modulates Milk-Induced Immune Inflammatory Response in Milk-Hypersensitive Adults
Pelto, L., Salminen, S., & Isolauri, E. (1996) · Nutrition Today · doi:10.1097/00017285-199611001-00015 · Cited by 15
Cited by
The Microbiota–Gut–Brain Axis in Psychiatric Disorders
Góralczyk-Bińkowska, A., Szmajda-Krygier, D., & Kozłowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911245 · Cited by 495
“It includes the vagal nerve, the HPA axis, the production of bacterial metabolites, immune mediators, and entero–endocrine signaling [50,99].”
BackgroundGut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 301
The role of probiotics and prebiotics in modulating of the gut-brain axis
Ansari, F., Neshat, M., Pourjafar, H., Jafari, S. M., Samakkhah, S. A., & Mirzakhani, E. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1173660 · Cited by 200
The Role of Gut Dysbiosis in the Pathophysiology of Neuropsychiatric Disorders
Anand, N., Gorantla, V. R., & Chidambaram, S. B. (2022) · Cells · doi:10.3390/cells12010054 · Cited by 171
Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options
Kumar, A., Pramanik, J., Goyal, N., Chauhan, D., Sivamaruthi, B. S., Prajapati, B. G., & Chaiyasut, C. (2023) · Pharmaceuticals · doi:10.3390/ph16040565 · Cited by 154
Metadata
- Authors
- Alli, S. R., Gorbovskaya, I., Liu, J. C. W., Kolla, N. J., Brown, L., & Müller, D. J.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- Great Scott Consulting, New York, NY, USA
- Corresponding author
- Müller, Daniel J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-04-19
- Volume
- 23
- Issue
- 9
- Pages
- 4494
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9101152
- OpenAlex
- W4224298193
- Cited by
- 202
- References
- 121
- Citations by year
- 2026: 34 · 2025: 67 · 2024: 55 · 2023: 34 · 2022: 12
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Toronto
- Temerty Faculty of Medicine, University of Toronto
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, major depressive disorder, depression, prebiotics, probiotics, synbiotics, microbial diversity, beta diversity, alpha diversity, microbial taxa abundance, depressive symptoms, microbiota-based therapy
- MeSH terms
- Gastrointestinal Microbiome, Depression, Major Depressive Disorder, Humans, Probiotics, Prebiotics, Synbiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.